Anti-cardiolipin and anti-beta 2 glycoprotein I antibodies in patients with type 1 diabetes (notice n° 276760)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02435cam a2200361 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250117194021.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mrizak, Chaima |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Anti-cardiolipin and anti-beta 2 glycoprotein I antibodies in patients with type 1 diabetes |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 22 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | AimTo determine the frequency of anti-phospholipid antibodies (aPL) in particular anti-cardiolipin antibodies (aCL) and anti-beta 2 glycoprotein I antibodies (aβ2GPI) in Tunisian patients with type 1 diabetes.Patients and methodsOne hundred and two patients with type 1 diabetes (34 children, 68 adults) were studied. As control groups, we used sera of 156 adults and 65 children without type 1 diabetes. aCL and aβ2GPI were detected by ELISA.ResultsThe frequency of aPL was significantly higher in type 1 diabetes patients than in control group (18.6% vs. 5.9%, p ConclusionFemale adults with type 1 diabetes had high frequency of aCL and aβ2GPI. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | ObjectifDéterminer la fréquence des anticorps antiphospholipides (aPL) en particulier les anticorps anti-cardiolipine (aCL) et anti-bêta 2 glycoprotéine I (aβ2GPI) chez des patients tunisiens atteints de diabète de type 1.Patients et méthodesL’étude a porté sur 102 patients atteints de diabète de type 1 (34 enfants, 68 adultes). Soixante-cinq enfants et 156 adultes sains ont servi comme groupe témoin. Les aCL et aβ2GPI ont été recherchés par ELISA.RésultatsLa fréquence de aPL était significativement plus élevée chez les patients atteints de diabète de type 1 que chez le groupe témoin (18,6 % vs. 5,9 %, p ConclusionLes femmes adultes atteintes de diabète de type 1 présentaient une fréquence élevée des aCL et des aβ2GPI. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | diabète de type 1 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Tunisie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | aCL |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adultes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | enfants |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | aβ2GPI |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | children |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | aCL |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Tunisia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adults |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | type 1 diabetes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | aβ2GPI |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mankai, Amani |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghozzi, Mariam |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Melayah, Sarra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghedira, Ibtissem |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Annales de Biologie Clinique | 81 | 5 | 2023-09-01 | p. 521-529 | 0003-3898 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-annales-de-biologie-clinique-2023-5-page-521?lang=en&redirect-ssocas=7080">https://shs.cairn.info/revue-annales-de-biologie-clinique-2023-5-page-521?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux